Skip to main content

Annovis Bio, Inc. (NYSE: ANVS) Investor Securities Class Action Lawsuit 08/17/2021

  • If you purchased shares of Annovis Bio, Inc. (NYSE: ANVS), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

October 12, 2021 - The case was voluntarily dismissed. August 17, 2021 - An investor in shares of Annovis Bio, Inc. (NYSE: ANVS) filed a lawsuit in the U.S. District Court for the Eastern District of Pennsylvania over alleged violations of Federal Securities Laws by Annovis Bio, Inc. in connection with certain allegedly false and misleading statements made between May 21, 2021 and Jul...



You must register (for free) or login to view the entire case.